Compugen (CGEN) EBITDA Margin (2009 - 2026)
Compugen recorded quarterly EBITDA Margin of 414.38% in Q1 2026, up 12.74% quarter-over-quarter from 367.56% in Q1 2025, and up 4683.0% year-over-year from 8.66% in Q1 2025.
Compugen's EBITDA Margin history runs 2 years deep, the most recent figure standing at 414.38% for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 414.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 414.38% |
| Dec 31, 2025 | 83.23% |
| Sep 30, 2025 | -417.40% |
| Jun 30, 2025 | -2,006.28% |
| Mar 31, 2025 | 367.56% |
| Dec 31, 2024 | -508.70% |
| Sep 30, 2024 | 26.24% |
| Jun 30, 2024 | -304.33% |
| Mar 31, 2024 | 331.85% |
| Dec 31, 2023 | 53.75% |
| Dec 31, 2022 | -47.05% |
| Dec 31, 2020 | -454.55% |
| Sep 30, 2018 | -42.72% |
| Dec 31, 2016 | -16,484.91% |
| Sep 30, 2016 | -11,381.43% |
| Jun 30, 2016 | -1,412.90% |
| Mar 31, 2016 | -9,538.71% |
| Dec 31, 2015 | -8.75% |
| Sep 30, 2015 | -3,019.21% |
| Jun 30, 2015 | -3,117.94% |
| Mar 31, 2015 | -1,232.36% |
| Dec 31, 2014 | -17.02% |
| Sep 30, 2014 | -267.35% |
| Jun 30, 2014 | -168.94% |
| Mar 31, 2014 | -155.23% |
| Dec 31, 2013 | -222.99% |
| Sep 30, 2013 | -276.86% |
| Jun 30, 2013 | -21,450.00% |
| Mar 31, 2013 | -2,446.91% |
| Dec 31, 2012 | -2,866.42% |
| Sep 30, 2012 | -3,355.56% |
| Dec 31, 2010 | -1,210.53% |
| Jun 30, 2010 | -117.13% |
| Mar 31, 2010 | -2,174.40% |
| Dec 31, 2009 | -7,804.00% |
| Sep 30, 2009 | 2,108.33% |